Cargando…

Anti-Sars-Cov-2 Antibody and T-Cell Responses Using Deep T-Cell Receptor Immunosequencing after Vaccination Among Healthy Individuals and Patients with Multiple Myeloma or Lymphoma

Detalles Bibliográficos
Autores principales:	Takamatsu, Hiroyuki, Ikeda, Daisuke, Terao, Toshiki, Yamashita, Takeshi, Urushihara, Ryota, Hatano, Yuzuki, Hirose, Nana, Yamada, Natsu, Murata, Ryoichi, Miyamoto, Toshihiro, Matsue, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:	Oral Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665221/ http://dx.doi.org/10.1182/blood-2022-158721

Ejemplares similares

144. Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection
por: Dalai, Sudeb C, et al.
Publicado: (2021)

Immune monitoring technology primer: immunosequencing
por: Kirsch, Ilan
Publicado: (2015)

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma
por: Urushihara, Ryota, et al.
Publicado: (2023)

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
por: Terao, Toshiki, et al.
Publicado: (2020)

Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2022)

Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in highly public receptors
por: Chu, Nathaniel D., et al.
Publicado: (2019)

Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria
por: Narita, Kentaro, et al.
Publicado: (2021)

Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence
por: Kitadate, Akihiro, et al.
Publicado: (2021)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
por: Tsushima, Takafumi, et al.
Publicado: (2021)

Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

LB17. Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Diagnosis and Characterization of Early Lyme Disease
por: Dalai, Sudeb C, et al.
Publicado: (2021)

Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
por: Terao, Toshiki, et al.
Publicado: (2021)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Automated analysis of immunosequencing datasets reveals novel immunoglobulin D genes across diverse species
por: Bhardwaj, Vinnu, et al.
Publicado: (2020)

Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
por: Yoroidaka, Takeshi, et al.
Publicado: (2021)

Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
por: Matsunami, Masatoshi, et al.
Publicado: (2021)

Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
por: Tsushima, Takafumi, et al.
Publicado: (2022)

Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report
por: Kamura, Yuya, et al.
Publicado: (2022)

Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging society
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma
por: Suehara, Yasuhito, et al.
Publicado: (2017)

Antibody response to COVID-19 vaccination in patients with lymphoma
por: Narita, Kentaro, et al.
Publicado: (2022)

Histamine Regulates Molecular Clock Oscillations in Human Retinal Pigment Epithelial Cells via H(1) Receptors
por: Morioka, Eri, et al.
Publicado: (2018)

S237: THE GENETIC SUBTYPES AND THE TUMOR MICROENVIRONMENT SIGNATURES ARE ASSOCIATED WITH DISTINCT OUTCOMES IN PERIPHERAL T-CELL LYMPHOMA
por: Suehara, Yasuhito, et al.
Publicado: (2023)

Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide
por: Terao, Toshiki, et al.
Publicado: (2021)

Regulation of immune cell responses by semaphorins and their receptors
por: Kumanogoh, Atsushi, et al.
Publicado: (2012)

Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
por: Kitadate, Akihiro, et al.
Publicado: (2020)

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation
por: Takamatsu, H., et al.
Publicado: (2017)

Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era
por: Takamatsu, Hiroyuki, et al.
Publicado: (2015)

S189: PROTEOGENOMIC LANDSCAPE OF MULTIPLE MYELOMA
por: Ramberger, Evelyn, et al.
Publicado: (2023)

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma
por: Abe, Yoshiaki, et al.
Publicado: (2019)

Combination of Clptm1L and TMEM207 Expression as a Robust Prognostic Marker in Oral Squamous Cell Carcinoma
por: Hano, Kimika, et al.
Publicado: (2021)

Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival
por: Fujisawa, Manabu, et al.
Publicado: (2014)

Automatic digital quantification of bone marrow myeloma volume in appendicular skeletons - clinical implications and prognostic significance
por: Nishida, Yuki, et al.
Publicado: (2017)

Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas
por: Kitadate, Akihiro, et al.
Publicado: (2018)

OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy
por: Tahri, Sabrin, et al.
Publicado: (2022)

EZH2 dependent epigenetic landscape in adult T cell leukemia and Tax immortalized cells
por: Fujikawa, Dai, et al.
Publicado: (2015)

Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study
por: Suzuki, Kenshi, et al.
Publicado: (2016)

Pomalidomide‐bortezomib‐dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMM
por: Sunami, Kazutaka, et al.
Publicado: (2020)

Neovascular Niche for Human Myeloma Cells in Immunodeficient Mouse Bone
por: Iriuchishima, Hirono, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cjj7lm7unhqp6l20jpobvl4ndl